Positive Results


University of British Columbia & International Team Discover rsACE2 may Inhibit COVID-19 & Trial to Commence

A University of British Columbia investigator led an international team that has discovered an experimental drug that effectively blocks the cellular door to SARS-CoV-2 used to infect its hosts (humans). The group previously offered the first genetic evidence that...

Pin It on Pinterest